Short-course daptomycin lock and systemic therapy for catheter-related bloodstream infections: a retrospective cohort study in cancer patients with surgically implanted devices

References

• Ziegler MJ, Pellegrini DC, Safdar N. Attributable mortality of central-line associated bloodstream infection: systematic review and meta-analysis. Infection. 2014;43:29–36.
   PubMed Web of Science ®Google Scholar
• Nesher L, Rolston kV. The current spectrum of infection in cancer patients with chemotherapy related neutropenia. Infection. 2014;42:5–13.10.1007/s15010-013-0525-9
   PubMed Web of Science ®Google Scholar
• The Joint Commission. Preventing central-line associated bloodstream infections. A global challenge, a global Perspective. 2013. http://www.jointcommission.org/assets/1/18/clasbi_monograph.pdf
   Google Scholar
• Fagan RP, Edwards JR, Park BJ, Fridkin SK, Magill SS. Incidence trends in pathogen-specific central line-associated bloodstream infections in US intensive care units, 1990–2000. Infect Control Hosp Epidemiol. 2013;34:893–899.10.1086/671724
   PubMed Web of Science ®Google Scholar
• Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter‐related infection: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009;49:1–45.10.1086/599185
   PubMed Web of Science ®Google Scholar
• Raad I, Davis S, Khan A, Tarrand J, Elting L, Bodey GP. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol. 1992;13:215–221.10.2307/30147100
   PubMed Web of Science ®Google Scholar
• O’Horo JC, Silva GLM, Safdar N. Anti-infective locks for treatment of central line-associated bloodstream infection: a systematic review and meta-analysis. Am J Nephrol. 2011;34:415–422.10.1159/000331262
   PubMed Web of Science ®Google Scholar
• O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;39:S1–34.
   Google Scholar
• Funalleras G, Fernández-Hidalgo N, Borrego A, Almirante B, Planes AM, Rodríguez D, Ruiz I, Pahissa A. Effectiveness of antibiotic-lock therapy for long-term catheter-related bacteremia due to gram-negative bacilli: a prospective observational study. Clin Infect Dis. 2011;53:e129–e132.10.1093/cid/cir551
   PubMed Web of Science ®Google Scholar
• Estes R, Theusch J, Beck A, Pitrak D, Mullane KM. Activity of daptomycin with or without 25 percent ethanol compared to combinations of minocycline, EDTA, and 25 percent ethanol against methicillin-resistant Staphylococcus aureus isolates embedded in biofilm. Antimicrob Agents Chemother. 2013;57:1998–2000.10.1128/AAC.01129-12
   PubMed Web of Science ®Google Scholar
• Aumeran C, Guyot P, Boisnoir M, Robin-Hennequin C, Vidal M, Forestier C, et al. Activity of ethanol and daptomycin lock on biofilm generated by an in vitro dynamic model using real subcutaneous injections ports. Eur J Clin Microbiol Infect Dis. 2013;32:199–206.10.1007/s10096-012-1732-5
   PubMed Web of Science ®Google Scholar
• Meije Y, Almirante B, Del Pozo JL, Martín MT, Fernández-Hidalgo N, Shan A, et al. Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection. J Infect. 2014;69:548–552.10.1016/j.jinf.2014.01.001
   Web of Science ®Google Scholar
• Castagnola E, Amoroso L, Banov L, Faraci M, Loy A, Moscatelli A, et al. Activity of linezolid and daptomycin against methicillin-resistant coagulase-negative staphylococci with increased MIC for vancomycin isolated from blood cultures in pediatric patients. J Chemother. 2015;26:273–5.
   Web of Science ®Google Scholar
• Dominguez-Herrera J, Docobo-Perez F, Lopez-Rojas R, Pichardo C, Ruiz-Valderas R, Lepe JA, et al. Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy. 2012;56:613–617.10.1128/AAC.05606-11
   PubMed Web of Science ®Google Scholar
• LaPlante KL, Mermel LA. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol Dial Transplant. 2007;22:2239–2246.10.1093/ndt/gfm141
   PubMed Web of Science ®Google Scholar
• Stewart PS, Davison WM, Steenbergen JN. Daptomycin rapidly penetrates a staphylococcus epidermidis biofilm. Antimicrob Agents Chemother. 2009;53:3505–3507.10.1128/AAC.01728-08
   PubMed Web of Science ®Google Scholar
• Vassallo M, Dunais B, Roger PM. Antimicrobial lock-therapy in central line-associated bloodstream infections: a systematic review. Infection. 2015;43:389–398.10.1007/s15010-015-0738-1
   PubMed Web of Science ®Google Scholar
• Cirioni O, Mocchegiani F, Ghiselli R, Silvestri C, Gabrielli E, Marchionni E, et al. Daptomycin and Rifampin alone and in combination prevent vascular graft biofilm formation and emrgence of antibiotic resistance in a subcutaneous rat pouch model of Staphylococcal infection. Eur J Vasc Endovasc Surg. 2010;40:817–822.10.1016/j.ejvs.2010.08.009
   PubMed Web of Science ®Google Scholar
• Del Pozo JL, Rodil R, Aguinaga A, Yuste JR, Bustos C, Montero A, et al. Daptomycin lock therapy for grampositive long-term catheter-related bloodstream infections. Int J Clin Pract. 2012;66:305–308.10.1111/j.1742-1241.2011.02830.x
   PubMed Web of Science ®Google Scholar
• Tatarelli P, Parisini A, Del Bono V, Mikulska M, Viscoli C. Efficacy of daptomycin lock therapy in the treatment of bloodstream infections related to long-term catheter. Infection. 2014;43:107–9.
   PubMed Web of Science ®Google Scholar
• Provonost P, Needahm D, Berenholtz S. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355:2725–2732.10.1056/NEJMoa061115
   PubMed Web of Science ®Google Scholar
• The European Committee on Breakpoint Susceptibility Testing. Breakpoints tables for interpretation of MICs and zone diameters. Version 4.0. 2014. http://www.eucast.org
   Google Scholar
• Lee JY, Ko KS, Peck KR, Oh WS, Song JH. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. J Antimicrob Chemother. 2006;57:1110–1115.10.1093/jac/dkl098
   PubMed Web of Science ®Google Scholar
• Van Praagh ADG, Li T, Zhang S, Arya A, Chen L, Zhang XX, et al. Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections. Antimicrob Agents Chemother. 2011;55:4081–4089.10.1128/AAC.00147-11
   PubMed Web of Science ®Google Scholar
• Bestul MB, VandenBussche HL. Antibiotic Lock technique: review of the literature. Pharmacotherapy. 2005;25:211–227.10.1592/phco.25.2.211.56947
   PubMed Web of Science ®Google Scholar
• Dreesen M, Foulon V, Spriet I, Goosens GA, Hiele M, Pourrcq De, et al. Epidemiology of catheter-related infections in adult patients receiving home parenteral nutrition: a systematic review. Clin Nutr. 2012;31:602–608.10.1016/j.clnu.2012.02.013
   PubMed Web of Science ®Google Scholar
• Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, et al. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother. 2007;51:1656–1660.10.1128/AAC.00350-06
   PubMed Web of Science ®Google Scholar
• Mekni MA, Bouchami O, Achour W, Ben Hassen A. Strong biofilm production but not adhesion virulence factors can discriminate between invasive and commensal Staphylococcus epidermidis strains. APMIS. 2012;120:605–11.10.1111/apm.2012.120.issue-8
   PubMed Web of Science ®Google Scholar